Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Nilova (Nilotinib) 150mg Capsules
Nilova (Nilotinib) 150mg Capsules, manufactured by Sun Pharmaceuticals Ltd., is a specialized medication indicated for the treatment of blood cancer, offering targeted therapy to inhibit cancer cell growth.
Uses of Nilova (Nilotinib) 150mg Capsules
Nilova (Nilotinib) 150mg Capsules are used for:
Treatment of chronic myeloid leukemia (CML) in adults.
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults and pediatric patients.
Benefits of Nilova (Nilotinib) 150mg Capsules
Targets and inhibits specific proteins responsible for the growth and survival of cancer cells.
Improves progression-free survival and overall survival rates in patients with CML and Ph+ ALL.
Offers a well-tolerated oral formulation, enhancing convenience and compliance with therapy.
Mechanism of Action of Nilova (Nilotinib) 150mg Capsules
Nilova (Nilotinib) 150mg Capsules contain nilotinib, a tyrosine kinase inhibitor that selectively inhibits BCR-ABL, c-KIT, and PDGFR kinases. By blocking these signaling pathways, nilotinib prevents the proliferation and survival of leukemia cells, leading to disease regression and improved clinical outcomes.